Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tyrosine-protein kinase receptor FLT3 inhibitor PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Myeloid 1 D007951 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109328